Skip to content

Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias

Evaluation of Potential Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04151966
Enrollment
104
Registered
2019-11-05
Start date
2019-07-22
Completion date
2021-12-01
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardioversion

Brief summary

Researchers are trying to determine if heart injury occurs in subjects who undergo direct current cardioversion.

Detailed description

External transthoracic direct current (DC) cardioversion is a commonly used method of terminating cardiac arrhythmias. Conventional wisdom indicates that external DC cardioversion causes myocardial injury. Previous research has shown that DC cardioversion resulted in myocardial injury as evidenced by increased levels of cardiac troponin, even though those changes were modest. Many of these studies evaluated monophasic defibrillators and older, less sensitive cardiac troponin assays. The current standard is now to use modern biphasic defibrillators and new high sensitivity cardiac troponin assays (hs-cTnT). It is conceivable that the newer defibrillators may not cause myocardial injury. It would be important to understand if myocardial injury occurs in this setting and its approximate magnitude as it would the interpretation of hs-cTnT values in patients and therefore influenced diagnoses. It may be if a threshold energy level can be identified that is would also influence the choice of energy used to deliver the shock in this situation. A previous preliminary study documented no evidence of myocardial injury after elective DC cardioversion with modern day defibrillators. We aim to validate and expand that study here at Mayo Clinic Rochester.

Interventions

DIAGNOSTIC_TESTBlood sample collection

Blood sample collection for markers of myocardial injury

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are undergoing elective direct current cardioversion, either externally or via the patient's internal cardioverter-defibrillator

Exclusion criteria

* Patients under age 18 * Patients with myocardial infarction, coronary artery bypass grafting or any invasive cardiac procedure in the previous six weeks * Pregnant patients * Patients who cannot provide informed consent because of cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Myocardial injuryBaseline, 6-24 hours post procedureChanges in high sensitivity cardiac troponin T (hs-cTnT) or troponin I (hs-cTnI) assay

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026